Please login to the form below

Not currently logged in
Email:
Password:

GSK vaccines business management shift

Jean Stephenne has been appointed as chairman of GlaxoSmithKline (GSK) Biologicals as part of GSK's planned succession strategy

Jean Stephenne has been appointed as chairman of GlaxoSmithKline (GSK) Biologicals as part of GSK's planned succession strategy.

Mr Stephenne will assume his new position with immediate effect while continuing in his current role as president, GSK Biologicals. Over the next two years operational responsibility for GSK Biologicals will move to Dr Moncef Slaoui, who continues in his current role as chairman of research and development. 

CEO of GSK, Andrew Witty, commented: "Succession planning is fundamental to GSK's long-term success and today's changes are clear evidence that we are taking proactive steps to maintain excellent leadership in our business. Jean has built a world-leading vaccines business and as chairman will continue to be instrumental in driving forward our public health agenda, while Moncef has more than 17 years experience working in the vaccines area and has played a critical role in developing the strong pipeline we have today."

According to Mr Witty, these changes to the business will ensure a continued focus on development and delivery of GSK's vaccine pipeline.

15th March 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics